patent - ColoHealth

EDP Biotech Received U.S. Patent for CA11-19™ Biomarker, Methods and Compositions for Screening and Detecting Colorectal Cancer

by Jessica Etheridge | Sep 5, 2017 | News and Events

EDP Biotech Received U.S. Patent for CA11-19™ Biomarker, Methods and Compositions for Screening and Detecting Colorectal Cancer Knoxville, TN September 5, 2017 – EDP Biotech Corporation, a global in vitro diagnostic innovator of simple blood-based cancer diagnostic...

EDP Biotech Received U.S. Patent for CA11-19™ Biomarker, Methods and Compositions for Screening and Detecting Colorectal Cancer

Topics

Recent Posts

Legal